Contract HHSD2002016M90063P
Maxim Biomedical, Inc · Department Of Health And Human Services · July 5, 2016
Maxim Biomedical, Inc was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on July 5, 2016 for $6,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Rockville, MD. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on April 19, 2021. If all options are exercised, the contract could reach $12,000.
Contract details
- PIID
- HHSD2002016M90063P
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Rockville, MD
- First action
- July 5, 2016
- Latest action
- April 19, 2021
Description
IGCF::
Modification timeline
-
April 19, 2021Mod 1$-6.2K
-
July 5, 2016Base award$12.4K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSD2002016M90063P?
Contract HHSD2002016M90063P is a federal contract awarded to Maxim Biomedical, Inc by Department Of Health And Human Services on July 5, 2016 for $6,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract HHSD2002016M90063P?
Maxim Biomedical, Inc won contract HHSD2002016M90063P from Department Of Health And Human Services.
How much is contract HHSD2002016M90063P worth?
Contract HHSD2002016M90063P has obligated $6,000 to date, with a total potential value of $12,000 if all options are exercised.